title: The prevalence of anti-HCV antibody in risk groups and blood donors.
abstract: Anti-HCV antibody was detected in 1.9% of the blood donors in University Hospital. Among the risk groups, 33.3% of the patients with post-transfusion hepatitis were tested positive for anti-HCV antibody. The anti-HCV antibody was detected in 30% of the IDU. Haemodialysis patients, patients with acute and chronic hepatitis and patients with liver cirrhosis appeared to have increased risk of Hepatitis C virus infection. The results indicate that the frequency of HCV infection increases with the exposure to blood or blood products.
authors.affiliation: Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala, Lumpur.
authors.forename: K P
authors.initials: KP
authors.lastname: Ng
authors.forename: T L
authors.initials: TL
authors.lastname: Saw
authors.forename: N W
authors.initials: NW
authors.lastname: Wong
authors.forename: K L
authors.initials: KL
authors.lastname: Goh
authors.forename: S Y
authors.initials: SY
authors.lastname: Chuah
authors.forename: M
authors.initials: M
authors.lastname: Nagaratnam
mesh_terms: D001782:Blood Donors; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects; D015819:Substance Abuse, Intravenous / Q000150:complications; D065227:Transfusion Reaction
chemical_list: D018937:Hepatitis C Antibodies